EO-2401
- Generic Name
- EO-2401
A Novel Therapeutic Vaccine (EO2401) in Metastatic Adrenocortical Carcinoma, or Malignant Pheochromocytoma/Paraganglioma
Phase 1
Terminated
- Conditions
- Adrenocortical CarcinomaPheochromocytomaParaganglioma
- Interventions
- First Posted Date
- 2019-12-05
- Last Posted Date
- 2024-11-12
- Lead Sponsor
- Enterome
- Target Recruit Count
- 70
- Registration Number
- NCT04187404
- Locations
- 🇫🇷
Chu Lille, Lille, France
🇫🇷Assistance Publique - Hôpitaux de Marseille - Hôpital Nord, Marseille, France
🇫🇷Institut Gustave Roussy, Villejuif, France
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath